PhD in Drug Discovery, Medicinal Chemistry, Chemical Biology, or Structural Biophysics and In Silico Modelling at GSK and University of Strathclyde University of Strathclyde in United Kingdom

P22) New tools for bioconjugation using novel rearrangement reactions is a fully funded PhD project at the University of York , delivered through the EPSRC Centre for Doctoral Training in Chemical Synthesis for a Healthy Planet (CSHP CDT) in partnership with the University of Oxford. The project sits at the interface of organic chemistry , synthetic chemistry , chemical biology , biotechnology , and applications in antibiotics and bacterial PROTACs . The research will develop new sustainable too...

CMAC is advertising a final call for 3 fully funded CEDAR PhD projects starting October 2026 . These opportunities are aimed at STEM graduates and are based at the University of Leeds , The University of Sheffield , or The University of Strathclyde . The CEDAR programme offers world-class training , access to lab facilities , international networking , and hands-on experience across academia and industry. A notable feature is the chance to complete placements with leading pharmaceutical companie...

PhD studentships are available through the University of Strathclyde’s collaborative research partnership with GSK. The opportunity is for PhD research in Medicinal Chemistry , Chemical Biology , and Structural Biophysics , with studentships starting in October 2027 . Funding covers home/UK fees only . The post does not mention a stipend, international fee coverage, or other financial details. The announcement is shared by Laura Paterson, Strathclyde Manager of the Collaborative GSK Research Pro...

University College London is advertising a Postdoctoral Research Fellow in Mass Spectrometry within the UCL Mass Spectrometry Science Technology Platform (MS-STP) in London. The role sits in a highly collaborative environment supporting structural biology, proteomics, single-cell biology, and spatial biology research. The project focuses on cyclic antimicrobial peptide–lipid interactions at molecular resolution. Working with Professor Alethea Tabor and Professor Kostas Thalassinos , the successf...

Fully funded PhD opportunity in medicinal chemistry at Newcastle University , within the Newcastle Medicinal Chemistry Group. The project focuses on high-throughput chemistry and direct-to-biology screening , with supervision involving Mike Waring and Hannah Stewart, and collaboration with Charles A. and Liz McFaddin at Eli Lilly and Company . This is a research-focused doctoral opening for candidates interested in drug discovery, screening workflows, and modern medicinal chemistry approaches. T...